Aker BioMarine Investor Relations Material
Latest events
Q1 2025
Aker BioMarine
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aker BioMarine
Access all reports
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications. Aker BioMarine AS operates through Fish Oils and Pelagic Protein segments. Its products include astaxanthin; fish oil; EPA; acetyl-L-carnitine (ALCAR); omega-3 phospholipids; and omega-3 fatty acids. It also offers products that contain its products that contain astaxanthin in skin care preparations. Aker BioMarine AS markets its products under the AkerBioSolutions brand to food companies and manufacturers of dietary supplements, as well as to producers of livestock feed for hens and pigs.
Key slides for Aker BioMarine
Q1 2025
Aker BioMarine
Q4 2024
Aker BioMarine
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
AKBM
Country
🇳🇴 Norway